Risks in dealing with Indian equities today.
Matein Khalid Global Investing
India is the most expensive major emerging market in the world at 20 times forward earnings, an unjustifiable metric at this time. (AFP)
After a stellar 28 per cent return in 2017, the BSE Sensex (down 2 per cent) and the NSE Nifty 50 indices in India been a disappointment in 2018 to date. The emerging markets convulsions in May were compounded by the political shock for the BJP in Karnataka. The financial markets have also been alert due to the oil price related slippage in India's current account deficit (every $10 rise in Brent means a 0.50 per cent rise in the Indian CAD), the depreciation in the rupee, poor bank earnings due to increased provisions, distress in small caps/SME, earnings downgrades in 2018, outflows by foreign funds from Dalal Street and the increasing realisation that the RBI was far too dovish on inflation and will have to do a policy U-turn that will mean at least two more rate hikes to take the policy rate to 6.75 per cent.
India is the most expensive major emerging market in the world at 20 times forward earnings, an unjustifiable metric at a time when earnings growth expectations are inflated, tax collection has dismal (thus a rise in the fiscal deficit) and interest rates are set to rise. While a positive monsoon and strong private consumption creates opportunities in Indian equities, my preferred strategy is to short the Sensex at 35,600 points and the Nifty at 10800 for a 8-10 per cent correction that is highly probable this summer. Note the Nifty Midcap 100 index has fallen 13 per cent in 2018, a classic response to higher rates and lower investor flows. This index has the potential to fall another 20 per cent in 2018. Fourth-quarter earnings growth was dismal, a 8 per cent decline due to increases in bank provisions. Ex-financials, Nifty sales was up 15 per cent and profit after tax was up 5-7 per cent in the fourth quarter, a decent if not blowout performance.
Bank provisions rise when their asset quality deteriorates and this is a chilling omen for the short term simply not priced into the stratosphere valuations of both the Sensex and the Nifty. Inflation due to high commodities prices will also force the Reserve Bank of India to go hawkish at its next monetary policy conclave, even though it raised interest rates on June 6. This will exacerbate weakness in earnings growth in media, consumer, healthcare and cement shares. Pharma faces competitive and regulatory headwinds in the US. Telecoms and cement lack pricing power. Obviously, Indian IT will be a beneficiary of the depreciated rupee and the spectacular bull market in Silicon Valley tech shares. The Modi government's focus on urban housing and rural spending is bullish for infrastructure stocks. The rise in gross refining margins and high oil prices is bullish for energy shares.
I doubt that the Nifty can rise much above 10,800 points in the current macro milieu as a rise in interest rates, a rise in political risk and fall in earnings per share growth is an argument for a lower valuation multiple, possibly as low as 16-17 times forward earnings. However, there is no reason to expect a bear market in India, even if the BJP faces a credible threat from a united opposition in the 2019 general election and the 20-22 per cent estimates for 2018 earnings growth are way too high. Sectors to avoid like the plague? Telecom, pharma and real estate, where Modinomics assault on black money has triggered a "Black Death" in asset values. It is far easier to pinpoint stocks that will be credible buys after a 8-10 per cent market correction. My preferred stocks in India are Mahindra and Mahindra, Maruti Suzuki, HDFC Bank, Nestle, Infosys, TCS, Spice Jet, and Apollo Hospitals.
While I can easily envisage Maruti Suzuki trading at 10,000 rupees sometime in 2019, I prefer to buy its shares somewhere in the ?7,400-?7,600 range. Maruti wholesale volumes are growing at a 26 per cent rate while there is robust demand for the new hatchback model Swift across India, with waiting periods and minimal dealer discounts. The firm operates at 100 per cent capacity utilisation even as Suzuki will expand its Gujarat plant next year. Maruti Suzuki is one of the most exciting revenue/margin growth stories in India. It is entirely possible that the shares trade at 28 times fiscal 2020 estimates or ?10,000 in the next 12 months. I concede this is one of the world's most expensive auto stocks yet its earnings predictability and sheer growth potential justifies its premium valuation.
The writer is a global equities strategist and fund manager. He can be contacted at firstname.lastname@example.org.
Copyright [c] 2018 Khaleej Times. All Rights Reserved. Provided by SyndiGate Media Inc. ( Syndigate.info ).
|Printer friendly Cite/link Email Feedback|
|Publication:||Khaleej Times (Dubai, United Arab Emirates)|
|Date:||Jun 10, 2018|
|Previous Article:||Can a trust be exempted from the Income-tax Act of India?|
|Next Article:||Will euro-dollar rate fall further to 1.15?|